Haemonetics says CSL Plasma expects U.S. rollout of its devices at all centers by end-2027
HAE•CSL Plasma expects to complete the rollout of Haemonetics’ NexSys PCS devices with Persona PLUS across all current U.S. centers by the end of 2027; Haemonetics said fiscal 2027 guidance is unchanged.
1. Rollout plans
Haemonetics disclosed an update on its non-exclusive U.S. supply agreement with CSL Plasma. The rollout’s scope and timing may change, implementation details are still being determined, and Haemonetics plans to provide an impact update on its November 2026 second-quarter earnings call.
